Dragonetti, Giulia
 Distribuzione geografica
Continente #
NA - Nord America 1.137
AS - Asia 965
EU - Europa 576
SA - Sud America 211
Continente sconosciuto - Info sul continente non disponibili 48
AF - Africa 27
OC - Oceania 2
Totale 2.966
Nazione #
US - Stati Uniti d'America 1.099
SG - Singapore 480
BR - Brasile 179
CN - Cina 172
SE - Svezia 106
DE - Germania 99
FR - Francia 94
IT - Italia 90
VN - Vietnam 81
IN - India 64
IE - Irlanda 42
GB - Regno Unito 35
ID - Indonesia 29
JP - Giappone 27
RU - Federazione Russa 23
FI - Finlandia 17
BD - Bangladesh 16
CA - Canada 16
HK - Hong Kong 16
KR - Corea 15
MX - Messico 14
AT - Austria 13
IQ - Iraq 12
PL - Polonia 12
ZA - Sudafrica 11
AR - Argentina 9
ES - Italia 9
NL - Olanda 9
TR - Turchia 9
PK - Pakistan 7
CO - Colombia 5
VE - Venezuela 5
CH - Svizzera 4
EC - Ecuador 4
EG - Egitto 4
MA - Marocco 4
UA - Ucraina 4
AZ - Azerbaigian 3
BE - Belgio 3
CZ - Repubblica Ceca 3
IL - Israele 3
JO - Giordania 3
KZ - Kazakistan 3
MY - Malesia 3
NP - Nepal 3
PE - Perù 3
PY - Paraguay 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
DK - Danimarca 2
DZ - Algeria 2
EU - Europa 2
GT - Guatemala 2
KE - Kenya 2
KW - Kuwait 2
PH - Filippine 2
TW - Taiwan 2
UZ - Uzbekistan 2
AL - Albania 1
AM - Armenia 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CL - Cile 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GR - Grecia 1
HR - Croazia 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
MN - Mongolia 1
NO - Norvegia 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SC - Seychelles 1
SI - Slovenia 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
ZM - Zambia 1
ZW - Zimbabwe 1
Totale 2.920
Città #
Singapore 271
Ashburn 148
Chandler 134
San Jose 133
Dublin 42
Beijing 40
Chicago 37
New York 36
Hyderabad 35
Ho Chi Minh City 34
Munich 34
The Dalles 34
Hefei 33
Los Angeles 32
Jakarta 28
Tokyo 26
Frankfurt am Main 24
Lauterbourg 24
Milan 23
St Louis 21
Marseille 19
Rome 17
Santa Clara 17
Hanoi 16
Hong Kong 16
Boston 15
Nuremberg 15
Bremen 14
Dallas 14
Princeton 14
San Mateo 13
Seoul 13
São Paulo 13
Washington 13
Moscow 11
Orem 11
Kent 10
Council Bluffs 9
Poplar 9
Chennai 8
Denver 8
Helsinki 8
Wilmington 8
Brasília 7
London 7
Paris 7
Roubaix 7
Johannesburg 6
Boardman 5
Brooklyn 5
Buffalo 5
Dhaka 5
Düsseldorf 5
Mexico City 5
Portsmouth 5
Rio de Janeiro 5
Turku 5
Vienna 5
Warsaw 5
Amsterdam 4
Ann Arbor 4
Baghdad 4
Charlotte 4
Falls Church 4
Jiaxing 4
Lappeenranta 4
Mumbai 4
North Bergen 4
Pune 4
Shanghai 4
Toronto 4
Wroclaw 4
Amman 3
Ankara 3
Atlanta 3
Brno 3
Brussels 3
Busto Arsizio 3
Cattolica 3
City of London 3
Cleveland 3
Dearborn 3
Florence 3
Fortaleza 3
Guarulhos 3
Haiphong 3
Hải Dương 3
Kuala Lumpur 3
Lahore 3
Manchester 3
Montreal 3
Nanjing 3
Perugia 3
Phoenix 3
Querétaro 3
Seattle 3
Valladolid 3
Almaty 2
Anápolis 2
Aracaju 2
Totale 1.702
Nome #
Extramedullary Involvement in Acute Myeloid Leukemia. A Single Center Ten Years' Experience 158
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 149
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA) 147
Candidaemia in haematological malignancy patients from a SEIFEM study: Epidemiological patterns according to antifungal prophylaxis 146
Invasive aspergillosis in relapsed/refractory acute myeloid leukaemia patients: Results from SEIFEM 2016-B survey 145
COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA) 130
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings 122
Developments in identifying and managing mucormycosis in hematologic cancer patients 120
Disseminated geosmithia argillacea infection in a patient with ph-positive acute lymphoblastic leukemia. Case report and literature review 118
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey 116
Invasive aspergillosis in relapsed/refractory acute myeloid leukaemia patients: Results from SEIFEM 2016-B survey 113
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry 112
COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA 107
Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey 102
Impact of invasive aspergillosis occurring during first induction therapy on outcome of acute myeloid leukaemia (SEIFEM-12B study) 101
Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report 100
Pharyngeal microbial signatures are predictive of the risk of fungal pneumonia in hematologic patients 100
'Real-life' analysis of the role of antifungal prophylaxis in preventing invasive aspergillosis in AML patients undergoing consolidation therapy: Sorveglianza Epidemiologica Infezioni nelle Emopatie (SEIFEM) 2016 study 99
A High-Risk Profile for Invasive Fungal Infections Is Associated with Altered Nasal Microbiota and Niche Determinants 96
Prospective multicenter study on infectious complications and clinical outcome of 230 unfit acute myeloid leukemia patients receiving first-line therapy with hypomethylating agents alone or in combination with Venetoclax 92
Rhodotorula infection in haematological patient: Risk factors and outcome 90
SARS-CoV-2 Infection In Patients With Mastocytosis: An EPICOVIDEHA Report 88
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry 88
Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry 86
Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey 82
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post–CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey 81
Rhodotorula infection in haematological patient: Risk factors and outcome 78
Totale 2.966
Categoria #
all - tutte 13.535
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.535


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022117 2 0 2 7 6 6 1 14 16 9 20 34
2022/2023384 45 43 24 61 32 44 27 31 44 9 18 6
2023/2024295 12 56 25 19 12 67 30 1 5 10 20 38
2024/2025698 15 8 37 37 45 10 41 27 120 102 147 109
2025/20261.382 218 25 89 169 225 89 233 74 74 110 45 31
2026/202741 41 0 0 0 0 0 0 0 0 0 0 0
Totale 2.966